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Background
The goal of wrestlers during a competitive season is to
maintain or lose body weight without compromising ath-
letic performance. However, some studies have reported
decrements in exercise performance associated with
weight loss and/or the strain of a competitive season. The
purpose of this study, therefore, was to examine the effects
of 8 week beta-alanine (β-ala) supplementation on exer-
cise performance in Division II collegiate wrestlers during
a competitive season.
Methods
25 college wrestlers (age 18 to 22 y) volunteered to partic-
ipate in this study, and 18 subjects (mean BMI 24.7 ± 3.7)
completed the study. Each participant ingested 4 g/d of β-
ala in an open-label manner during the final eight weeks
of their competitive season. The subjects followed a stand-
ard training protocol for collegiate wrestling as dictated by
the head coach. They were also required to maintain uni-
form body mass during the entire eight weeks, as per
weight bracket allowance during the competitive season.
Before and after supplementation, subjects performed a
400 m sprint and 90 degree flexed-arm hang to exhaus-
tion. Immediately prior to and following the pre treat-
ment and post treatment 400 m sprint, subjects blood
lactate was taken via finger stick and analyzed to deter-
mine lactate increase during the 400 m sprint.
Results
The subjects showed significant decrease (p < 0.01) in 400
m sprint time (-3.5 s ± 2.4 s, mean ± SD) and significant
increase (p < 0.01) in 90 degree flexed-arm hang (+ 8.5 s
± 8.35 s, mean ± SD). No significant changes (p > 0.05) in
blood lactate values were observed.
Conclusion
The results of our study suggest that supplementation of
β-ala may improve exercise performance in wrestlers dur-
ing a competitive season. Because of the design of this
experiment, it is impossible to identify exactly how much
of the positive effects experienced by the subjects was a
direct result of the supplementation. However, due to the
large increase in performance and the similarity of results
in comparison to other β-ala studies, we feel our study
suggests efficacy of β-ala supplementation. The ergogenic
effects of β-ala supplementation during a competitive
wrestling season needs to be confirmed in placebo-con-
trolled trials.
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